This cluster has a common complex mechanism of expression regulation and the formation of a drug resistance phenotype due to the work of a group of ABC transporter genes and may be associated with the response of a breast tumour to neoadjuvant chemotherapy. Here, ABCG2 is linked to breast neoplasm.